MNBTD
VIVO

Moody National Bank Trust Division’s Meridian Bioscience Inc VIVO Stock Holding History

Moody National Bank Trust Division’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-238
Closed -$4K – 1410
2018
Q4 		$4K Buy
+238
New +$4.06K ﹤0.01% 1027

Other funds holding VIVO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Moody National Bank Trust Division's VIVO Position: Q1 2019 in Review

Moody National Bank Trust Division sold out of Meridian Bioscience Inc (VIVO) in Q1 2019, closing a stake of 238 shares — an estimated $4K sold.

Moody National Bank Trust Division first reported a position in VIVO in Q4 2018 and held it in 1 quarter. The position peaked at $4K in Q4 2018. 183 funds tracked by Wall St. Rank hold VIVO as of Q1 2019.

  • Moody National Bank Trust Division reported no remaining Meridian Bioscience Inc position as of Q1 2019 after selling out during the quarter.
  • Moody National Bank Trust Division sold 238 Meridian Bioscience Inc shares in Q1 2019, an estimated $4K.
  • Moody National Bank Trust Division first reported a position in Meridian Bioscience Inc in Q4 2018 and held it in 1 quarter.
  • Moody National Bank Trust Division's Meridian Bioscience Inc position peaked at $4K in Q4 2018.
  • 183 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2019.

Based on Moody National Bank Trust Division's 13F filing for Q1 2019, filed 11 Apr 2019.